Bacterial Pathogens of Urinary Tract in Diabetic patients at Tishreen University Hospital

Author:

Atrash Mais1,Daoud Nazih1,Naser Hassan2

Affiliation:

1. Department of Biochemistry and Microbiology, Faculty of Pharmacy, Tishreen University, Lattakia, Syria.

2. Department of Urology, Faculty of Medicine, Tishreen University, Lattakia, Syria.

Abstract

Urinary tract infections (UTIs) in diabetic patients are more severe and frequent than in others, with more serious potential complications. Our study aims to investigate the bacterial uropathogens in this group in order to avoid random treatments and the resulting possibility of treatment failure and exacerbation of bacterial resistance to used antibiotics, and therefore, maintaining the patients' lifestyle and reducing the economic burden. The study was conducted in the period between October (2021) and June (2022) during which 386 urine samples were collected from diabetic patients attending Tishreen University Hospital in Lattakia city - Syria. The results of urine culture showed that 184 diabetic patients (of both sexes) had a urinary tract infection, with a percentage of 47.66%, where infections were higher in females (74.46%) than in males (25.54%), With a higher rate of infection in patients older than 55 years. E. coli was the most common uropathogen and was found in 45.65% of the isolates, followed by S. aureus (18.48%), Streptococcus species (10.33%), Enterobacter (8.15%), P. aeruginosa (6.52%), and K. pneumoniae (4.35%). The isolated uropathogens were resistant to the most of the commonly used antibiotics. Meropenem and imipenem were the most effective antibiotics against most of Gram-negative bacteria, as is the case of E. coli, which showed high sensitivity levels to both of them, followed by nitrofurantoin, amikacin, and ampicillin/sulbactam. As for Gram-positive bacteria, staphylococci showed the highest sensitivity levels to amikacin, followed by imipenem and vancomycin, whereas Streptococci spp. were primarily sensitive to meropenem, followed by nitrofurantoin.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3